These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 27182769)

  • 1. Clozapine administration in clinical practice: once-daily versus divided dosing.
    Takeuchi H; Powell V; Geisler S; DeSanti M; Fervaha G; Agid O; Kane JM; Remington G
    Acta Psychiatr Scand; 2016 Sep; 134(3):234-40. PubMed ID: 27182769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clozapine Once-Daily Versus Divided Dosing Regimen: A Cross-sectional Study in Japan.
    Kitagawa K; So R; Nomura N; Tsukahara M; Misawa F; Kodama M; Uchida H; Bies R; Straubinger T; Banker C; Mizuno Y; Mimura M; Takeuchi H
    J Clin Psychopharmacol; 2022 Mar-Apr 01; 42(2):163-168. PubMed ID: 34879387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital use of antipsychotic agents in 1989 and 1993: stable dosing with decreased length of stay.
    Baldessarini RJ; Kando JC; Centorrino F
    Am J Psychiatry; 1995 Jul; 152(7):1038-44. PubMed ID: 7793440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
    Wheeler AJ
    Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription practices and attitude of psychiatrists towards clozapine: A survey of psychiatrists from India.
    Grover S; Balachander S; Chakarabarti S; Avasthi A
    Asian J Psychiatr; 2015 Dec; 18():57-65. PubMed ID: 26498722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clozapine once- versus multiple-daily dosing: a two-center cross-sectional study, systematic review and meta-analysis.
    Kuzo N; Haen E; Ho DM; Takeuchi H; Piras M; Eap CB; de Filippis R; Homan P; Kane JM; Roy MA; Paulzen M; Schoretsanitis G
    Eur Arch Psychiatry Clin Neurosci; 2023 Oct; 273(7):1567-1578. PubMed ID: 36580106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine administered once versus twice daily: does it make a difference?
    Procyshyn RM; Vila-Rodriguez F; Honer WG; Barr AM
    Med Hypotheses; 2014 Feb; 82(2):225-8. PubMed ID: 24360486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of once- versus twice-daily perphenazine dosing on clinical outcomes: an analysis of the CATIE data.
    Takeuchi H; Fervaha G; Uchida H; Suzuki T; Bies RR; Grönte D; Remington G
    J Clin Psychiatry; 2014 May; 75(5):506-11. PubMed ID: 24569099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone].
    Bret P; Bonnet F; Bret MC; Jaffré A
    Encephale; 2002; 28(4):329-42. PubMed ID: 12232542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of clozapine use in Maryland and in Victoria, Australia.
    Conley RR; Kelly DL; Lambert TJ; Love RC
    Psychiatr Serv; 2005 Mar; 56(3):320-3. PubMed ID: 15746507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From conventional to atypical antipsychotics and back: dynamic processes in the diffusion of new medications.
    Leslie DL; Rosenheck RA
    Am J Psychiatry; 2002 Sep; 159(9):1534-40. PubMed ID: 12202274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined use of amisulpride and clozapine for patients with treatment-resistant schizophrenia.
    Cook B; Hoogenboom G
    Australas Psychiatry; 2004 Mar; 12(1):74-6. PubMed ID: 15715745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatic tolerance of atypical antipsychotic drugs].
    Dumortier G; Cabaret W; Stamatiadis L; Saba G; Benadhira R; Rocamora JF; Aubriot-Delmas B; Glikman J; Januel D
    Encephale; 2002; 28(6 Pt 1):542-51. PubMed ID: 12506267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of different dosing regimens of risperidone and olanzapine in schizophrenia.
    Takeuchi H; Fervaha G; Lee J; Agid O; Remington G
    Eur Neuropsychopharmacol; 2015 Mar; 25(3):295-302. PubMed ID: 25649680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethnic comparisons of antipsychotic use in schizophrenia.
    Wheeler A; Humberstone V; Robinson E
    Aust N Z J Psychiatry; 2008 Oct; 42(10):863-73. PubMed ID: 18777230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of smoking cessation on psychiatric inpatients treated with clozapine or olanzapine.
    Cole ML; Trigoboff E; Demler TL; Opler LA
    J Psychiatr Pract; 2010 Mar; 16(2):75-81. PubMed ID: 20511731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of clozapine for non-treatment-resistant patients with schizophrenia.
    Galletly CA; Clark CR; McFarlane AC; Weber DL
    Psychiatr Serv; 1999 Jan; 50(1):101-3. PubMed ID: 9890589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the Effect of the Changes in FDA Guidelines for Clozapine Monitoring.
    Sultan RS; Olfson M; Correll CU; Duncan EJ
    J Clin Psychiatry; 2017; 78(8):e933-e939. PubMed ID: 28742291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescribing and monitoring clozapine in Christchurch.
    McKean A; Vella-Brincat J; Begg E
    Australas Psychiatry; 2008 Aug; 16(4):263-7. PubMed ID: 18668375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.